    <SEC-DOCUMENT>0001610618-20-000025-index.html : 20200429
    <SEC-HEADER>0001610618-20-000025.hdr.sgml : 20200429
    <ACCEPTANCE-DATETIME>20200429160533
    ACCESSION NUMBER:		0001610618-20-000025
    CONFORMED SUBMISSION TYPE:	DEF 14A
    PUBLIC DOCUMENT COUNT:		4
    CONFORMED PERIOD OF REPORT:	20200429
    FILED AS OF DATE:		20200429
    DATE AS OF CHANGE:		20200429
    EFFECTIVENESS DATE:		20200429

    FILER:

    	COMPANY DATA:
    		COMPANY CONFORMED NAME:			Cidara Therapeutics, Inc.
    		CENTRAL INDEX KEY:			0001610618
    		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
    		IRS NUMBER:				461537286
    		STATE OF INCORPORATION:			DE
    		FISCAL YEAR END:			1231

    	FILING VALUES:
    		FORM TYPE:		DEF 14A
    		SEC ACT:		1934 Act
    		SEC FILE NUMBER:	001-36912
    		FILM NUMBER:		20830244

    	BUSINESS ADDRESS:
    		STREET 1:		6310 NANCY RIDGE DRIVE
    		STREET 2:		SUITE 101
    		CITY:			SAN DIEGO
    		STATE:			CA
    		ZIP:			92121
    		BUSINESS PHONE:		858-752-6170

    	MAIL ADDRESS:
    		STREET 1:		6310 NANCY RIDGE DRIVE
    		STREET 2:		SUITE 101
    		CITY:			SAN DIEGO
    		STATE:			CA
    		ZIP:			92121

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	K2 THERAPEUTICS, INC.
    		DATE OF NAME CHANGE:	20140611
    </SEC-HEADER>
    <DOCUMENT>
    <TYPE>DEF 14A
    <SEQUENCE>1
    <FILENAME>cdtxdef14a2020.htm
    <DESCRIPTION>DEFINITIVE PROXY STATEMENT
    <TEXT>
    Document 1 - file: cdtxdef14a2020.htm

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>2
    <FILENAME>cdtxlogoa13.jpg
    <TEXT>
    Document 2 - file: cdtxlogoa13.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>3
    <FILENAME>proxycard01.jpg
    <TEXT>
    Document 3 - file: proxycard01.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>4
    <FILENAME>proxycard02.jpg
    <TEXT>
    Document 4 - file: proxycard02.jpg

    </DOCUMENT>
    </SEC-DOCUMENT>